Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Transdermal System in Healthy Subjects
NCT07818330Phase 1Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Dec 2026
01
Overview
Phase 1, single-arm trial of dexmedetomidine. Primary endpoints: Incidence of Treatment-Emergent Adverse Events and Incidence of Serious Adverse Events. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07818330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07818330.